ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /化合物

Fentanyl Citrate

HCID 13810
ノートを作成反応を作成見積依頼を出す
印刷プレビュー

データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます

基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
990-73-8
標準SMILES
CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.O=C(O)CC(O)(CC(=O)O)C(=O)O
InChIKey
IVLVTNPOHDFFCJ-UHFFFAOYSA-N
分子式
C28H36N2O8
平均分子量
528.6 g/mol
単同位体質量
528.24716611

概要

Fentanyl citrate is the citric acid salt of fentanyl, comprising equimolar amounts of citric acid and fentanyl. A -opioid receptor agonist, it is a potent opioid analgesic used in the management of labour pain, postoperative pain, and chronic intractable cancer pain. It is also widely used as the analgesic component of balanced anaesthesia. It has a role as an opioid analgesic and a mu-opioid receptor agonist. It contains a fentanyl.

名称と識別子

優先名称
Fentanyl Citrate
IUPAC
2-hydroxypropane-1,2,3-tricarboxylic acid;N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide

名称と別名

FENTANYL CITRATE990-73-8LeptanalOraletPhentanyl citrateActiqAbstralLazandaOnsolisInstanylFentanyl buccalMcN-JR-4263-49
名称をさらに表示
Fentanyl citrate ciiSUBLIMAZE PRESERVATIVE FREEMUN5LYG46HN-(1-Phenethyl-4-piperidyl)propionanilide citrateFENTANYL CITRATE PRESERVATIVE FREEKw-2246N-(1-Phenethyl-4-piperidyl)propionanilide dihydrogen citrateN-(1-Phenethyl-4-piperidinyl)propionanilide dihydrogen citrate

データベース識別子

CAS
990-73-8
PubChem CID
13810
DTXSID
DTXSID80243933
ChEMBL
CHEMBL688
ChEBI
CHEBI:31602
UNII
MUN5LYG46H
EC Number
213-588-0

物性

構造計算による物性補完中

極性表面積
156 Ų
水素結合供与体数
4
水素結合受容体数
9
回転可能結合数
11
重原子数
38
形式電荷
0
複雑度
618

実験および物理化学的性質

Chemical ClassesOther Uses -> Pharmaceuticals
Human Drugs · 3 件

FDA approved drugs -> Active ingredient

EMA approved medicines: Human medicine

FDA approved drugs -> Active ingredient

Animal DrugsActive Ingredients (Fentanyl Citrate) -> FDA Greenbook

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Danger

H300 (100%): Fatal if swallowed [Danger Acute toxicity, oral]

P233, P260, P261, P262, P264, P270, P271, P272, P280, P284, P301+P316, P302+P352, P304+P340, P316, P320, P321, P330, P333+P317, P342+P316, P361+P364, P362+P364, P403, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 68 reports by companies from 11 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Regulatory InformationFentanyl citrate: HSNO Approval: HSR003800 Approved with controls
Other Safety InformationIMAP assessments - Propanamide, N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-,2-hydroxy-1,2,3-propanetricarboxylate (1:1): Environment tier I assessment
Hazards Summary · 1 件

Fentanyl is a solid. It is a Schedule II controlled substance. Fentanyl citrate is a strong analgesic used preoperatively, during surgery, and in the immediate postoperative period for its analgesic action. . . . Introduced into clinical practice in the 1960s, the analgesic fentanyl is 100 times more potent than morphine. [HSDB] TLV Basis is CNS impairment and respiratory depression; [ACGIH TLVs and BEIs]

Hazard Classes and CategoriesAcute Tox. 2 (100%)

安全と保護具

Threshold Limit Values (TLV) · 2 件

0.00001, inhalable particulate matter (Surface Level = 1 ug/100cm2)

0.00002, inhalable particulate matter

毒性情報

化学と産業

薬理情報

FDA Pharmacological Classification · 2 件

FENTANYL CITRATE

Opioid Agonist [EPC]; Full Opioid Agonists [MoA]

MeSH Pharmacological Classification · 4 件

Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS.

Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage.

Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS.

Ultrashort-acting anesthetics that are used for induction. Loss of consciousness is rapid and induction is pleasant, but there is no muscle relaxation and reflexes frequently are not reduced adequately. Repeated administration results in accumulation and prolongs the recovery time. Since these agents have little if any analgesic activity, they are seldom used alone except in brief minor procedures. (From AMA Drug Evaluations Annual, 1994, p174)

用途と製造

Use ClassificationAnimal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients

関連反応

5 件
反応記録を作成
HRID 8554 の反応式
HRID 8554反応物としてuspto-grants-2006_08
HRID 68194 の反応式
HRID 68194反応物としてuspto-grants-2014_09
HRID 68195 の反応式
HRID 68195反応物としてuspto-grants-2014_09
HRID 874079 の反応式
HRID 874079反応物としてuspto-grants-2015_03
HRID 874080 の反応式
HRID 874080反応物としてuspto-grants-2015_03

化合物ノート

読み込み中…

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
その他の操作
ノートを作成反応を作成見積依頼を出す
Adverse EffectsACGIH Carcinogen - Not Classifiable.